[Ischemic heart disease lethalities in the state of Rio de Janeiro between 1999 and 2003]

Gláucia Maria Moraes de Oliveira1, Carlos Henrique Klein, Nelson Albuquerque de Souza e Silva

  • 1Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Escola Nacional de Saúde Pública, Rio de Janeiro, RJ. glaucia@mls.com.br

Insights

High lethality rates for ischemic heart disease (IHD) procedures like coronary artery bypass graft (CABG) and percutaneous transluminal coronary angioplasty (PTCA) were observed in Rio de Janeiro. Optimized medical therapy may be a better option for many IHD patients.

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • Health Services Research

Context:

  • Ischemic heart disease (IHD) management in Rio de Janeiro (RJ) between 1999-2003.
  • Analysis of procedures within the Hospital Information System/Single Healthcare System (SIH/SUS).
  • Focus on coronary artery bypass graft (CABG) and percutaneous transluminal coronary angioplasty (PTCA).

Purpose:

  • To estimate the lethality rates of IHD, CABG, and PTCA procedures in RJ hospitals.
  • To compare lethality rates across different IHD classifications and treatments.
  • To evaluate the effectiveness of medical therapy versus interventional procedures.

Summary:

  • Lethality rates for IHD were 2.8% (angina), 16.2% (acute myocardial infarction), 2.9% (other acute IHD), and 3.9% (chronic IHD).
  • Adjusted lethality rates for CABG ranged from 1.9% to 12.8%, and for PTCA, it was 3.2%.
  • Medical therapy showed lower lethality (2.3% for CABG, 11.1% for PTCA) compared to procedures in some cases.

Impact:

  • Identified high lethality rates for IHD procedures, exceeding desirable levels, particularly for chronic IHD.
  • Suggests optimized medical therapy as a preferred option, reserving CABG and PTCA for severe cases.
  • Highlights the need for improved treatment strategies for cardiovascular diseases in the region.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...